TJP1 and chronic obstructive pulmonary disease: As shown in Additional file 1: Fig. S2A and S2B, compared with those of non-COPD patients, the lung tissue samples of COPD patients had significantly attenuated E-cadherin and ZO-1 protein levels and markedly enhanced α-SMA, vimentin, and N-cadherin protein levels.